Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Ipsen    IPN   FR0010259150

IPSEN (IPN)
Mes dernières consult.
Most popular
Real-time Quote. Real-time Tradegate - 11/21 08:15:59 pm
104.119 EUR   +1.88%
11/18 IPSEN : Firm to bring 350 new jobs
11/14 Lexicon Pharmaceuticals Reports Third Quarter 2017 Financial Resu..
11/10 IPSEN : supports awareness of Neuroendocrine Tumors (NET) and the NE..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Ipsen : supports awareness of Neuroendocrine Tumors (NET) and the NET Cancer Day on November 10, 2017

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/10/2017 | 04:24pm CET

NET Cancer Day on the 10th of November 2017, is an annual event dedicated to raising awareness of a rare cancer, neuroendocrine tumors (NET).


NET Cancer Day, a global initiative of the International Neuroendocrine Cancer Alliance (INCA) and its members, aims to inform and raise awareness of this often undetected and rare disease amongst the general public and medical institutions with the ultimate goal of providing patients with improved diagnosis and care as they live with NET.
Neuroendocrine tumors: An unusual type of cancer

For more information on NET disease and Cancer Day please visit:
International Neuroendocrine Cancer Alliance
Living with NETs

Livingwithnets.com Website and its contents are intended for an international audience, excluding the United States, Canada and France.

Ipsen SA published this content on 10 November 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 10 November 2017 15:23:04 UTC.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on IPSEN
01:14p IPSEN : promotes Alexis Vandier as general manager, France
11/18 IPSEN : Two firms in Wrexham expand to create 350 new jobs
11/18 IPSEN : Firm to bring 350 new jobs
11/14 Lexicon Pharmaceuticals Reports Third Quarter 2017 Financial Results and Prov..
11/10 IPSEN : supports awareness of Neuroendocrine Tumors (NET) and the NET Cancer Day..
10/31 IPSEN : launches acromunity.com a website designed with patients for patients
10/30 IPSEN : delivers strong sales growth of 22.6% for the third quarter of 2017 and ..
10/26 IPSEN : delivers strong sales growth of 22.6% for the third quarter of 2017 and ..
10/23 IPSEN : Holocaust survivor brings his story to Germanna Oct. 26
10/18 IPSEN : announces that phase 3 CELESTIAL trial of cabozantinib meets primary end..
More news
News from SeekingAlpha
10/26 Ipsen S.A. reports Q3 results
10/18 3 THINGS IN BIOTECH YOU SHOULD LEARN : October 18, 2017
10/16 Exelixis' Cabometyx successful in late-stage liver cancer study; shares ahead..
09/20 YOUR DAILY PHARMA SCOOP : Geron's Growth Potential, Ipsen's Xarmelo Approval, GS..
09/20 Premarket analyst action - healthcare
Financials (€)
Sales 2017 1 928 M
EBIT 2017 443 M
Net income 2017 288 M
Debt 2017 357 M
Yield 2017 0,91%
P/E ratio 2017 29,53
P/E ratio 2018 22,98
EV / Sales 2017 4,62x
EV / Sales 2018 3,97x
Capitalization 8 553 M
Chart IPSEN
Duration : Period :
Ipsen Technical Analysis Chart | IPN | FR0010259150 | 4-Traders
Technical analysis trends IPSEN
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Average target price 127 €
Spread / Average Target 24%
EPS Revisions
Managers
NameTitle
David D. Meek Chief Executive Officer
Marc M. P. de Garidel Non-Executive Chairman
Aymeric Le Chatelier Executive Vice President-Finance
Jonathan Barnsley Executive Vice President-Technical Operations
Alexandre P. LeBeaut Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
IPSEN48.76%10 042
JOHNSON & JOHNSON19.78%370 552
NOVARTIS11.20%220 012
ROCHE HOLDING LTD.-1.55%212 913
PFIZER8.90%210 711
MERCK AND COMPANY-6.23%147 550